- English
- Our Research Team
- Brooke Schneider
Dr. Brooke Schneider
Curriculum Vitae
2013 – present | Research psychologist, Clinical Neuropsychology Working Group, Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Germany |
2014 | Licensed as psychotherapist in cognitive behavioral therapy |
2012 – 2014 | Research psychologist, Adjunct faculty, Department of Psychology, University of Maryland, United States |
2012 | Licensed as psychotherapist, State of California, United States |
2010 – 2012 | Postdoctoral fellow in neuropsychology/geropsychology, West Los Angeles VA Hospital, California, United States |
2010 | Ph.D. dissertation on cognitive, psychological and health contributors to disability among urban black older adults, Wayne State University, Detroit, Michigan, United States |
2004 – 2006 | M.Sc. in clinical psychology, Wayne State University, Detroit, Michigan, United States |
2000 – 2004 | B.Sc. in psychology, biology, and neuroscience, Drake University, Des Moines, Iowa, United States |
Research Interests
- neuropsychological functioning in psychological and neurological disorders
- depression
- associations between age-related changes in health and cognition
- contribution of cultural differences to neuropsychological assessment
Selected Independent Research Funding
2016 | Funding for a study on medication adherence in individuals with psychosis by the Forschungsförderung durch Fakultätsmittel, University Medical Center Hamburg-Eppendorf |
2015 – 2017 | Young Investigator Award for a study entitled "Objective and Subjective Social Cognition in Schizophrenia" from the Brain and Behavior Research Foundation (NARSAD) |
Selected Publications
Schneider, B. C., Brüne, M., Bohn, F., Veckenstedt, R., Kolbeck, K., Krieger, E., Becker, A., Drommelschmidt, K.A., Englisch, S., Eisenacher, S., Lee-Grimm, S, Nagel, M., Zink, M. & Moritz, S. (2016). Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: Study protocol of a multi-center randomized controlled trial. BMC Psychiatry, 16, 51-65.
Schneider, B. C., Gross, A. L., Bangen, K. J., Skinner, J. C., Benitez, A., Glymour, M. M., Sachs, B.C., Regina, A.S., Sisco, S., Manly, J.J. & Luchsinger, J. A. (2014). Association of vascular risk factors with cognition in a multiethnic sample. Journal of Gerontology, Series B: Psychological Sciences and Social Sciences, 70(4), 532-544.
Schneider, B. C., Thoering, T., Cludius, B., & Moritz, S. (2015). Self-reported symptoms of attention-deficit/hyperactivity disorder: Rate of endorsement and association with neuropsychological performance in an adult psychiatric sample. Archives of Clinical Neuropsychology, 30(3), 186-191.
Moritz, S., Andreou, C., Schneider, B. C., Wittekind, C. E., Menon, M., Balzan, R. P., & Woodward, T. S. (2014). Sowing the seeds of doubt: A narrative review of metacognitive training in schizophrenia. Clinical Psychology Review, 34, 358-366.
Moritz, S., Veckenstedt, R., Andreou, C., Bohn, F., Hottenrott, B., Leighton, L., Pfueffer, U. & Roesch-Ely, D. (2014). Immediate, delayed and “sleeper” effects of megacognitive group training (MCT) in psychosis: A three-year follow-up investigation. JAMA Psychiatry, 71, 1103-1111.